期刊文献+

格尔德霉素基因工程高产菌株的构建和培养 被引量:5

Construction and Cultivation of Genetically-engineered Strain to Improve Geldanamycin Production
下载PDF
导出
摘要 在格尔德霉素产生菌吸水链霉菌17997(Streptomyces hygroscopicus 17997)中存在两种3-氨基-5-羟基苯甲酸(3-amino-5-hydroxybenzoic acid,AHBA)的生物合成基因簇,根据同源性可分为苯醌类和萘醌类。已证明其中苯醌类的AHBA生物合成基因簇负责格尔德霉素(geldanamycin,Gdm)起始单位的合成,而萘醌类的AHBA基因簇可能参与未知安莎化合物的生物合成。为提高吸水链霉菌17997菌种的Gdm发酵产量,并研究高产菌种在固体培养基上孢子的生长周期。采用基因阻断技术,将吸水链霉菌17997中的萘醌类AHBA生物合成基因簇(shnSOP)进行破坏,以获得ΔSOP菌株,从而减少对合成所需共同底物AHBA的争夺。HPLC分析结果表明ΔSOP菌株Gdm的发酵产量比原株提高185%。同时,通过孢子计数发现该菌株在固体培养基上的孢子生长经历2个周期,第2代孢子菌种的Gdm产量较高。 To improve the production of geldanamycin in Streptomyces hygroscopicus 17997, gene disruption was done to delete the naphthalenic AHBA genes (shnSOP), encoding the products that share the common biosynthetic substrates with geldanamycin. The resulting mutant strain (ASOP) was cultivated on a solid medium and the amount of spores collected from the plates was calculated from 5 to 14 days and the yield of geldanamycin was measured by HPLC. The geldanamycin production of the ASOP strain increased by 185% comparing with that of the parent strain. On solid medium, the ASOP strain underwent 2 cycles of sporulation and the growth of the second sporulation had the highest geldanamycin production.
机构地区 中国医学科学院
出处 《生物工程学报》 CAS CSCD 北大核心 2008年第1期15-20,共6页 Chinese Journal of Biotechnology
基金 科技部基础研究重大项目973前期研究专项(No.2001CCA00500)资助~~
关键词 吸水链霉菌17997 格尔德霉素 基因阻断 孢子形成周期 Streptomyces hygroscopicus 17997, geldanamycin, gene disruption, spore formation
  • 相关文献

参考文献17

  • 1Sasaki K, Yasuda H, Onodera K. Growth inhibition of vi. rus transformed cells in vitro and antitumor activity in vivo of geldanamycin and its derivatives. Journal of Antibiotic, (Tokyo), 1979,37(8): 849-951.
  • 2陶佩珍,娄志贤,姚天爵,张兴权,线素文,姚恩泰,刘玉珍,王淑琴.广谱抗病毒抗生素17997体内外抗病毒活性研究[J].中国抗生素杂志,1997,22(5):368-372. 被引量:42
  • 3Prodromou C, Roe SM, O'Brien R, et al. Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone. Cell, 1997, 90(1): 65-75.
  • 4Stebbins CE, Russo AA, Schneider C, et al. Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent. Cell, 1997, 89 (2): 239-250.
  • 5Goetz MP, Toft D, Reid J, et al. Phase Ⅰ trial of 17-allylamino- 17-demethoxygeldanamycin in patients with advanced cancer. Jounal of Clinical Oncology. 2005, 23(6): 1078-1087.
  • 6Glaze ER, Lambert AL, Smith AC, et al. Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)- 17-demeth oxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance. Cancer Chemotherapy Pharmacology, 2005, 56 (6): 637-647.
  • 7高群杰,尚广东,杨樱,孙桂芝,王以光,陶佩珍,娄志贤,姚天爵.Geldanamycin产生菌生物合成相关基因的克隆与分析[J].中国抗生素杂志,2002,27(1):13-17. 被引量:6
  • 8Ghisalba O, Niiesch J. Genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei.Ⅳ, identification of 3-amino-5-hydroxybenzoic acid as a direct precursor of the seven-carbon amino starterunit. Jounal of Antibiotics, (Tokyo), 1981, 34: 64-71.
  • 9Becker AM, Herlt AJ, Hilton GL, et al. 3-Amino-5- hydroxybenzoic acid in antibiotic biosynthesis.Ⅵ. Directed biosynthesis studies with ansamycin antibiotics. Jounal of Antibiotics (Tokyo), 1983, 36: 1323-1328.
  • 10He WQ, Wu LZ, Wang YG, et al. Identification of AHBA biosynthetic genes related to geldanamycin biosynthesis in Streptomyces hygroscopicus 17997. Current Microbiology, 2006, 52 (3): 197-203.

二级参考文献18

  • 1邓子新,周秀芬.质粒在大肠杆菌和链霉菌FR-008之间的属间接合转移[J].遗传,1994,16(6):7-10. 被引量:9
  • 2[1]Sasaki k, Rinehart K L Jr, SlompG, et al. Geldanamyin. 1: Structure assignment [J]. J Am Chem Soc,1970;92: 7591
  • 3[2]Kim C-G, Yu TW, FryhleC, et al. 3-Amino-5-hydroxybenzoic acid sythase, the terminal enzyme in the formation of the precursor of mC7N Units in rifamycin and related antibiotics [J]. J BiolChem,1998;273(11):6030
  • 4[3]August P R, TangL, Yoon Y J. et al. Biosythesis of the ansamycin antibiotic rifamycin: Deduction from the molecular analysis of the rif biosynthetic gene cluster of Amycolatopsis mediterranei [J]. Chem Biol, 1998: 5: 69
  • 5[4]Sambrook J, Frisch E F, Maniatis T, et al. Molecular cloning: alaboratory manual [M]. NY: Cold Spring Harbor Laboratory,1989:914,908,35,474,127
  • 6[5]Kieser T, Bibb M J, Buttner M J, et al. Practical Streptomyces genetics [M]. Norwich: The John Innes Foundation ,2000: 291,405,161,271
  • 7[6]Richardson M A, Kuhstoss S, Solenberg P, et al.A new shuttle cosmid vector, pkc505, for Streptomyces: its use in the cloning of three different spiramycin resistance genes from a Streptomyces ambofaciens library [J]. Gene, 1987;61:231
  • 8[7]Chen S, Bamberg D V, Hale V, et al. Biosythesis of ansatrienin and naphthomycin identification and analysis of two separate biosynthetic gene clusters in Streptomyces collinus Tü1892 [J]. Eur J Biochem,1999:261:98
  • 9陶佩珍,北京医学,1995年,1/2期,21页
  • 10Nechkers L. Hsp90 inhibitors as novel cancer chemotherapy agents[J]. Trends Mol Med, 2002, 8:S55

共引文献48

同被引文献122

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部